PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
WE Schmidt, JS Christiansen, M Hammer, MJ Zychma, J BuseVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73586-5
File:
PDF, 86 KB
english, 2009